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Injwy fromJ-Wire Fracture Injuryfrom Lead Extraction
i% Age M/F Lead Status Pts Age fvVF Lead Status
Death 5 26-S3 Z3 5 = protruded 8 60-S2 2/6 6 = no fraCtUre
Tamponade 13 21-S6 7/6 13= protruded 4 4S-76 113 2 = no fracture
Pericard. Effusion 5 54-75 1/4 5 = protruded 5 32-71 1/4 3 = no fracture
Atrial Pertoratlon 2 17-56 2/0 2 = protruded 2 45-SO 0/2 2 = nOfraCIUre
Embolism 3 5s-67 2/1 4 = emboiized
Hemopneumothorax 7 23-67 2!5 4 = fractured
Vascular Injury 11 33-S9 5/6 11 = fractured
ElectiveThoracotomy 24 23-S3 14/10 15= fractured
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BB (SD) RAA (SD) P value (t-test)., ,, .,
AFR 0.7 (0.6) 0,64 (0.24) 0,4 (NS)
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a to 3 months each of AAl or DDD pacing and evaluated after each
study period.
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